Marylyn Addo, MD, PhD, MSc, DTM&H, Pr. Dr. , Head of infectious diseases and Tropical medicine, I. Medizinische Klinik department, Universitätsklinikum Hamburg-Eppendorf, Germany.
After having received her medical degree from University of Bonn, she accomplished the Diploma in Tropical Medicine and Hygiene in London and won the Ralph A. Neal Memorial Prize. Her research activities brought her to Harvard Medical School in Boston, where she became Assistant Professor at the Ragon Institut and associate Director of the Harvard Center for AIDS Research (CFAR). In 2013 she moved back to Germany where she was appointed as Professor of Emerging Infections, at the Deutsches Zentrum für Infektionsforschung/Universitätsklinikum Hamburg-Eppendorf, working on the topic “Immunity and pathogenesis of newly emerging viral infections”.
Prof. Addo was awarded as Honorary Professor at the Nelson Mandela Medical School, University of KwaZulu-Natal, Durban, South Africa in 2013.
Her current research focuses on emerging viral diseases. She coordinated the randomized clinical trial of VSV-ZEBOV, one of the main and more successful experimental vaccines against Ebola virus disease. Furthermore Prof. Addo will be leading the german phase 1 clinical trial of promising vaccine against MERS coronavirus.